These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12537785)

  • 1. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
    Felberbaum RE; Küpker W; Diedrich K
    Reprod Biomed Online; 2002; 5 Suppl 1():68-72. PubMed ID: 12537785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of GnRH antagonists in the treatment of endometriosis.
    Küpker W; Felberbaum RE; Krapp M; Schill T; Malik E; Diedrich K
    Reprod Biomed Online; 2002; 5(1):12-6. PubMed ID: 12470539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
    Felberbaum RE; Germer U; Ludwig M; Riethmüller-Winzen H; Heise S; Buttge I; Bauer O; Reissmann T; Engel J; Diedrich K
    Hum Reprod; 1998 Jun; 13(6):1660-8. PubMed ID: 9688409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [GnRH antagonist].
    Yano T; Taketani Y
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():133-8. PubMed ID: 11235152
    [No Abstract]   [Full Text] [Related]  

  • 5. GnRH-antagonists in reproductive medicine.
    Griesinger G; Felberbaum R; Diedrich K
    Arch Gynecol Obstet; 2005 Dec; 273(2):71-8. PubMed ID: 15991015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of uterine fibroids with the LHRH antagonist: Cetrorelix].
    Felberbaum RE; Ludwig M; Diedrich K
    Contracept Fertil Sex; 1999 Oct; 27(10):701-9. PubMed ID: 10605180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues.
    van der Spuy ZM; Wood M; Fieggen G; Hendricks MS
    S Afr Med J; 1993 Jul; 83(7):510-3. PubMed ID: 8211493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
    De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
    Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of GnGH (GnRH-A) in gynecology].
    Ciardo A; Spina V; Aleandri V
    Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma.
    Waibel-Treber S; Minne HW; Scharla SH; Bremen T; Ziegler R; Leyendecker G
    Hum Reprod; 1989 May; 4(4):384-8. PubMed ID: 2526152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonists-antagonists--clinical applications.
    Shaw RW
    Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):109-16. PubMed ID: 2969835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gonadotropin releasing hormone (GnRH) antagonists--a new provocation in gynecology].
    Vladimirov Ia
    Akush Ginekol (Sofiia); 2002; 41(3):36-42. PubMed ID: 12145978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
    Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
    BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetrorelix in the treatment of female infertility and endometriosis.
    Finas D; Hornung D; Diedrich K; Schultze-Mosgau A
    Expert Opin Pharmacother; 2006 Oct; 7(15):2155-68. PubMed ID: 17020439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.
    Chrisp P; Goa KL
    Drugs; 1991 Feb; 41(2):254-88. PubMed ID: 1709853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
    Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
    Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.